artificialselecter Wednesday, 03/18/20 11:29:47 AM
Re: mfdesigner post# 60213 0
Post #
60231
of 62809
https://www.pharmatechsolutions.co/assets/ins...ro!_PP.pdf

Here is the link. This tech looks great, nice idea to use monoclonal Ab for a specific viral envelope marker. Read current biophysics/bioelectronics/materials science journals and you’ll see that many biosensor technologies have used a similar design. Concept has been validated in these additional studies.

I agree it would be refreshing to see false positive and false negative rates. But from what I’ve read, there can be a relatively large margin of error and FDA can still deem the test effective. These types of diagnostic tests have less stringent efficacy criteria than molecular amplification-based diagnostics.

Glty